9, 2023 /PRNewswire/ -- Eccogene announced today that it entered into an exclusive license agreement with AstraZeneca under which AstraZeneca will develop and commercialize Eccogene's small molecule GLP-1 receptor agonist (GLP-1RA) ECC5004 for the potential treatment of obesity, type-2 diabetes and other comorbidities
Confidence intervals overlapped in some strata, but directionality was stable, supporting robustness of the primary findings
"In vitro folding, functional characterization, and disulfide pattern of the extracellular domain of human GLP-1 receptor"
To test the effects of exogenous carnitine supplementation on the endogenous carnitine concentrations, the carnitine concentrations in various fish tissues were measured
You might think the stack underperformed relative to a single peptide, when the underlying issue was inconsistent composition or unclear handling history
While research is needed to quantify and identify the drivers, we hypothesize that there are likely many issues, Khan said